Market Overview

Merz Creates Americas Region, Expands Bob Rhatigan's Leadership Role


Frank Brandt-Pollmann promoted to Area Vice President – Latin

Merz, a global leader in medical aesthetics and neurotoxins, today
announced the appointment of Bob Rhatigan as Chief Executive Officer –
Americas. Expanding on his leadership of Merz's North American business,
Mr. Rhatigan will now assume responsibility for Latin America as well
and will oversee the overall commercial strategy for the newly-created
Americas Region. In addition, Frank Brandt-Pollmann has been promoted to
Area Vice President – Latin America and will lead Merz's business
operations across Latin America, reporting directly to Bob Rhatigan. The
changes go into effect September 1, 2018.

This press release features multimedia. View the full release here:

Bob Rhatigan, CEO - Americas (Photo: Business Wire)

Bob Rhatigan, CEO - Americas (Photo: Business Wire)

"We are confident that under the leadership of Bob Rhatigan and Frank
Brandt-Pollmann, Merz in the Americas will be well-positioned to execute
on our global vision to become the most admired, trusted and innovative
aesthetics and neurotoxin company," said Philip Burchard, CEO of Merz.
"Moreover, I would particularly like to thank Beat Neukom, Chief
Financial Officer – Merz Group, for his extraordinary commitment and
contributions as interim Region Head Latin America. For the past two
years, and in addition to his CFO responsibilities, Beat has led the
team in Latin America through significant change, with a focus on
increasing revenue in strategic business areas and establishing a
culture of collaboration across the region. This has led to a
significant acceleration of our business in Latin America and has put
Merz on a clear path of success for the future."

With the creation of this new Americas region, Merz is connecting and
strengthening its business in North and Latin America (LATAM), which is
home to some of the world's top aesthetics markets, including the US,
Brazil and Mexico. Together, physicians and patients in the Americas
represent more than half of the total aesthetic procedures performed
globally each year.1

"I am honored to accept this new leadership role within Merz, and I
believe that our increased focus on the Americas creates an exciting
strategic opportunity to strengthen our partnerships with customers in
these important markets," said Bob Rhatigan, CEO – Americas. "I'm
excited to take on the additional responsibility of LATAM, which has
grown considerably and established a strong foundation for future
success under the leadership of Beat Neukom over the past two years. I
also look forward to working closely with Frank Brandt-Pollmann to
leverage our combined resources and talented Merz teams in the LATAM
region to further unlock the potential of our portfolio and continue to
meet the evolving needs of physicians and patients across the Americas."

In his new role as CEO – Americas, Mr. Rhatigan will continue to be
based in Raleigh, NC, USA, reporting directly to Philip Burchard, CEO -
Merz. Mr. Rhatigan joined Merz in April 2017 as President and Chief
Executive Officer – North America.

"Over the past years, Merz in Latin America has experienced significant
growth, and I am grateful for this opportunity to work alongside Bob
Rhatigan to build on past achievements and lead the team in Latin
America to even greater performance," said Frank Brandt-Pollmann, Area
Vice President – Latin America. "As we look to the future, we will
continue to expand our portfolio offerings, intensify our focus on
customer needs, and build on our strong culture of leadership and
collaboration across Latin America."

In his new role as Area Vice President – Latin America, Mr.
Brandt-Pollmann will retain his current responsibilities as General
Manager for Brazil. Mr. Brandt-Pollmann joined Merz in September 2012
and brings more than 12 years of international pharmaceutical experience
in both operations and commercial roles. A German national, he has
professional experience in Europe and Asia Pacific as well as several
countries in Latin America.

Merz in the Americas

Merz has a direct presence in six countries in the Americas, as well as
a network of selected professional distribution partners in South and
Central America and the Caribbean. Merz in the Americas is headquartered
in Raleigh, North Carolina, and has facilities in Mesa, Arizona,
Franksville, Wisconsin as well as offices in Toronto, Canada, Mexico
City, Bogotá, Colombia, São Paolo, Brazil and Buenos Aires, Argentina.

Merz Worldwide

With approximately 3,000 employees and a direct presence in 28
countries, Merz is a global, family-owned aesthetics and neurotoxin
company based in Frankfurt, Germany. Privately held for 110 years, the
company is distinguished by its commitment to innovation, long-term
perspective and focus on profitable growth. In addition to its
comprehensive portfolio of medical aesthetic products in the device,
injectable and skincare categories, Merz also develops neurotoxin
therapy to treat neurologically-induced movement disorders. In fiscal
year 2016/17, Merz generated revenue of EUR 1,092.9 million. More
information is available at

1 Source: Global market research data on file

View Comments and Join the Discussion!